Interferon-gamma potentiation of lipopolysaccharide-induced eicosanoid release from human monocytes.
Interferon-gamma potentiation of lipopolysaccharide-induced eicosanoid release from human monocytes.
复制标题
干扰素-γ增强脂多糖诱导的人单核细胞释放类二十烷酸。
DOI:
10.1089/jir.1987.7.121
复制
发表时间:
1987
期刊:
影响因子:
--
通讯作者:
Garrison,SW
中科院分区:
文献类型:
--
作者:
Nichols,FC;Garrison,SW
Interferon-γ (IFN-γ) can act to potentiate lipopolysaccharide (LPS)-stimulated processes in mononuclear phagocytes, including interleukin-1 release and tumoricidal activity. The present investigation examined the capacity of IFN-γ to modulate LPS-stimulated prostaglandin E2(PGE2) and thromboxane B2(TxB2) release from counterflow isolated human monocytes. The release of PGE2and TxB2was compared for cells incubated with IFN-γ prior to treatment with LPS and for cells treated simultaneously with IFN-γ and LPS. Treatment of cells with IFN-γ prior to stimulation with LPS (10 μg/ml,Salmonella typhimurium) resulted in elevated prostaglandin E (by immunoassay) and [3H]PGE2release from monocytes when compared with LPS-treated cultures. In contrast, IFN-γ pretreatment did not potentiate labeled or immunoreactive TxB2release from LPS-treated monocytes. IFN-γ pretreatment without LPS stimulation did not result in elevated eicosanoid release over controls. In addition, continuous treatment of monocytes with both IFN-γ and LPS did not result in greater release of PGE2and TxB2than the summed individual effects of IFN-γ and LPS. These results indicate that IFN-γ selectively potentiates LPS-stimulated arachidonic acid conversion to PGE2and not TxB2in human monocytes. This effect was observed only for monocytes pretreated with IFN-γ prior to stimulation with LPS.